Nitta Toshikatsu, Ishii Masatsugu, Taki Masataka, Kubo Ryutaro, Hosokawa Norihiro, Ishibashi Takashi
Division of Surgery Gastroenterological Center, Medico Shunju Shiroyama Hospital, Osaka, Japan.
Cancer Diagn Progn. 2024 Nov 3;4(6):743-747. doi: 10.21873/cdp.10390. eCollection 2024 Nov-Dec.
BACKGROUND/AIM: Surgery for colon cancer requires covering a wide area and performing both tumor resection and precise lymph node dissection. Robotic left-sided colectomy (RLC) has not been thoroughly established due to the rarity of descending colon cancer. Therefore, we investigated 19 patients who underwent RLC for left-sided colon cancer.
Between January 2023 and July 2024, a total of 19 consecutive patients underwent robotic radical left colectomy, which included mobilization of the splenic flexure. We compared the intra- and postoperative factors between left-sided colectomy with and without stent placement.
Total operative time (p=0.002), console time (p=0.001), and lymph node harvest time (p=0.001) were significantly different. The total operative time with stent placement was longer than that without stent placement (421.6 vs. 302.0, p<0.01). Console time with stent placement was longer than that without stent placement (315.0 vs. 202.0, p<0.01). More lymph nodes were harvested with stent placement than without (33.1 vs. 11.0, p<0.01).
We did not experience any conversions to open surgery, and two Grade II complications were observed according to the Clavien-Dindo classification. Both total operative and console times were longer in cases with stent placement compared to those without. Nevertheless, we safely performed robotic left colectomy, regardless of whether the left-sided colon cancer was treated with stent placement, even in cases where the anastomosis overlapped naturally. Our postoperative outcomes showed no anastomosis-related complications. Therefore, RLC reconstruction using an intracorporeal overlap anastomosis is feasible for left-sided colon cancer, both in terms of intraoperative and postoperative outcomes.
背景/目的:结肠癌手术需要覆盖较大范围,并进行肿瘤切除和精确的淋巴结清扫。由于降结肠癌较为罕见,机器人辅助左侧结肠切除术(RLC)尚未得到充分确立。因此,我们对19例行RLC治疗左侧结肠癌的患者进行了研究。
2023年1月至2024年7月期间,共有19例连续患者接受了机器人辅助根治性左侧结肠切除术,其中包括脾曲游离。我们比较了放置支架和未放置支架的左侧结肠切除术的术中和术后因素。
总手术时间(p = 0.002)、控制台操作时间(p = 0.001)和淋巴结清扫时间(p = 0.001)存在显著差异。放置支架的总手术时间长于未放置支架的(421.6对302.0,p < 0.01)。放置支架的控制台操作时间长于未放置支架的(315.0对202.0,p < 0.01)。放置支架时清扫的淋巴结多于未放置支架时(33.1对11.0,p < 0.01)。
我们没有遇到任何转为开放手术的情况,根据Clavien-Dindo分类观察到2例Ⅱ级并发症。与未放置支架的病例相比,放置支架的病例总手术时间和控制台操作时间均更长。然而,无论左侧结肠癌是否接受支架置入治疗,即使在吻合自然重叠的情况下,我们都安全地实施了机器人辅助左侧结肠切除术。我们的术后结果显示无吻合相关并发症。因此,无论是术中还是术后结果,采用体内重叠吻合的RLC重建术治疗左侧结肠癌都是可行的。